Lucid Diagnostics receives VA contract for esophageal cancer test
Go back to Lucid Diagnostics receives VA contract for esophageal cancer test| (NASDAQ: LUCD) | Delayed: 1.02 +0.02 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.00 | 52 Week High | $ | |||
| Open | $1.02 | 52 Week Low | $ | |||
| Day High | $1.04 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $ | |||
| Volume | 587,647 | |||||
| (NASDAQ: PAVM) | Delayed: 5.45 -0.39 (6.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.84 | 52 Week High | $15.24 | |||
| Open | $5.88 | 52 Week Low | $10.50 | |||
| Day High | $5.88 | P/E | N/A | |||
| Day Low | $5.45 | EPS | $0.00 | |||
| Volume | 10,211 | |||||
